Free Trial
NYSE:ALC

Alcon Q3 2026 Earnings Results & Report

Alcon logo
$74.03 -1.11 (-1.48%)
Closing price 11/10/2026 03:59 PM Eastern
Extended Trading
$71.37 -2.66 (-3.59%)
As of 08:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alcon beat analyst expectations on both earnings and revenue in its Q3 2026 results, released November 10, 2026. The company reported EPS of $0.91 versus the $0.89 consensus estimate, while revenue of $2.74 billion topped the $2.68 billion estimate by $54.40 million. Revenue increased 4.9% year over year.

Earnings Announcement Details

Quarter
Q3 2026
Time
After Market Closes
Conference Call Date
Conference Call
8:00 AM ET
Live Event
Earnings Conference Call
Alcon Q3 2026
00:00 / 00:00
Live Transcript
Follow Audio

Alcon EPS Results

Actual EPS
$0.91
Consensus EPS
$0.89
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.79
EPS Beat Rate
6 of last 8 quarters

Alcon Revenue Results

Actual Revenue
$2.74 billion
Expected Revenue
$2.68 billion
Beat/Miss
Beat by +$54.40 million
YoY Revenue Growth
+4.90%

Earnings Documents

Alcon Q3 2026 Earnings FAQ

Alcon (NYSE:ALC) reported earnings of $0.91 per share for Q3 2026, beating the consensus estimate of $0.89. The report was announced on Tuesday, November 10, 2026.

Alcon reported revenue of $2.74 billion for Q3 2026, against a consensus estimate of $2.68 billion.

Alcon Earnings Headlines

Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
See More Alcon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Alcon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alcon and other key companies, straight to your email.

About Alcon

Alcon (NYSE:ALC) is a global eye-care company that develops, manufactures and markets products for eye surgery and vision care. Its surgical business serves ophthalmologists and other eye-care professionals with equipment, instruments, implantable lenses and other products used in procedures such as cataract and retinal surgery.

Alcon’s vision-care business includes contact lenses and products for eye health. Its portfolio includes daily and reusable lenses, as well as lubricating eye drops and other ocular-health products.

The company traces its origins to a pharmacy opened in Fort Worth, Texas, in 1945. Alcon became an independent, publicly traded company in 2019 after being separated from Novartis. It serves customers in more than 140 countries.

View Alcon Profile